I know you didn't say it and of course the JAT group has a fairly high Chinese shareholder component, I would say, but some posts here refer to JAT being a Chinese company.
This has always annoyed me as JAT is an Australian company. Sure there is a lot of Asian heritage Australians working for JAT and subsidiary's but they are still Australians. JAT has locals in China working for them as well. Most retail shareholders, who are actually JAT owners would, I'd say, be Australians. But do we really know. Anyhow some down rampers have said they wouldn't buy JAT shares because it is Chinese.
Personally I find the high work ethic of Asian heritage Australians a real benefit and this is part of the reason for putting my money on JAT.
Anyhow back to diversification of product. The more the merrier as far as I am concerned. Its probably best to mainly stick to a particular category of say fast moving health products as JAT has done. Do market research on the potential of new products. If something does not sell, even after all this, drop it like a stone.
GLTAH DYOR
- Forums
- ASX - By Stock
- JAT
- Should JAT concentrate only on IF
Should JAT concentrate only on IF, page-5
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JAT (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.46M |
Open | High | Low | Value | Volume |
45.0¢ | 45.0¢ | 45.0¢ | $4.425K | 9.833K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 33334 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 21502 | 0.450 |
1 | 50 | 0.425 |
3 | 22000 | 0.420 |
2 | 21300 | 0.410 |
4 | 40750 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 33334 | 1 |
0.550 | 51242 | 2 |
0.560 | 12073 | 3 |
0.590 | 20000 | 1 |
0.595 | 20000 | 1 |
Last trade - 15.40pm 12/11/2024 (20 minute delay) ? |
Featured News
JAT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online